바이오데식스 (BDSX) 주가

바이오데식스(BDSX)는 NASDAQ에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $29.55 (+2.57%), 시가총액 $0.15B, 52주 최저~최고 $0.25 ~ $19.40.

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company pr

핵심 지표

• 현재가: $29.55 (+2.57%)
• 시가총액: $0.15B
• 52주 최저~최고: $0.25 ~ $19.40
• 섹터: Healthcare
• 산업: Diagnostics & Research
• 거래소: NASDAQ

바이오데식스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

바이오데식스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 15.94
• 순이익률: -0.33%
• 영업이익률: -0.26%

자주 묻는 질문